N.Y. Court Issues Preliminary Injunction on Generic Wellbutrin

Law360, New York (December 29, 2003, 12:00 AM EST) -- The U.S. District Court for the Southern District of New York replaced the temporary restraining order it had issued on Nov. 26, 2003 with a preliminary injunction to prevent Eon Labs from introducing Bupropion, the generic equivalent of GlaxoSmithKline’s antidepressant Wellbutrin.

In addition, the Court set the amount of the bond GlaxoSmithKline is required to post at $3 million. The bond will be used to compensate Eon for any damages it suffers if the preliminary injunction is determined to have been improperly granted.

Separately, Andrx Group...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.